Display options
Share it on

J Nutr Metab. 2014;2014:861659. doi: 10.1155/2014/861659. Epub 2014 Nov 20.

Effects of canned pineapple consumption on nutritional status, immunomodulation, and physical health of selected school children.

Journal of nutrition and metabolism

Mavil May C Cervo, Luisito O Llido, Erniel B Barrios, Leonora N Panlasigui

Affiliations

  1. School of Nutrition, Philippine Women's University, 1004 Manila, Philippines.
  2. School of Nutrition, Philippine Women's University, 1004 Manila, Philippines ; Clinical Nutrition Services, St. Luke's Medical Center, 1102 Quezon City, Philippines.
  3. School of Statistics, University of the Philippines-Diliman, 1101 Quezon City, Philippines.

PMID: 25505983 PMCID: PMC4258310 DOI: 10.1155/2014/861659

Abstract

This randomized, controlled trial examined the effects of canned pineapple consumption on immunomodulation, nutritional status, and physical health of ninety-eight (98) school children with mean age of 8.44 ± 0.20. The study participants were divided into three groups: Group A (33) includes subjects who were not given canned pineapple, Group B (33) includes those who were given 140 g, and Group C (32) includes those given 280 g of canned pineapple for nine weeks. Each major group was further divided into two groups: normal (N) and underweight (U) based on 2007 WHO Growth Reference Standards. Sociodemographic, anthropometric, physical examination, dietary intake, hemoglobin level, and immunological data were analyzed. Results showed a decrease in incidence of viral and bacterial infections for both Group B and Group C (normal and underweight) after canned pineapple consumption. Granulocyte production increased by 0.77-26.61% for normal weight subjects and 14.95-34.55% for underweight. CD16+56 count augmented by 20.44-22.13% for normal weight and 3.57-15.89% for underweight subjects. Thus, intake of both one can (140 g) and two cans (280 g) of canned pineapple may shorten the duration and incidence of infection and may increase the production of granulocytes and CD16+56, but intake of two cans (280 g) demonstrated higher granulocyte and CD16+56 production. This trial is registered with Philippine Health Research Registry: PHRR140826-000225.

References

  1. Altern Ther Health Med. 2012 Sep-Oct;18(5):9-17 - PubMed
  2. Phytother Res. 2013 Feb;27(2):199-204 - PubMed
  3. Inflamm Bowel Dis. 2010 Dec;16(12):2012-21 - PubMed
  4. Planta Med. 2007 Oct;73(13):1377-83 - PubMed
  5. J Pharmacol Sci. 2007 Mar;103(3):267-74 - PubMed
  6. Comp Biochem Physiol C Toxicol Pharmacol. 2006 Aug;143(4):429-35 - PubMed
  7. Evid Based Complement Alternat Med. 2008 Mar;5(1):61-9 - PubMed
  8. J Nutr. 2006 Oct;136(10):2606-10 - PubMed
  9. Naunyn Schmiedebergs Arch Pharmacol. 2013 Oct;386(10):853-63 - PubMed
  10. Clin Immunol. 2008 Jul;128(1):66-74 - PubMed
  11. J Infect Dis. 2012 Aug 1;206(3):366-76 - PubMed
  12. Gut. 1998 Aug;43(2):196-202 - PubMed
  13. Onco Targets Ther. 2013 Apr 16;6:403-9 - PubMed
  14. J Nutr. 2000 Sep;130(9):2127-30 - PubMed
  15. Am J Clin Nutr. 2007 Dec;86(6):1754-64 - PubMed
  16. Can J Physiol Pharmacol. 1998 Apr;76(4):373-80 - PubMed
  17. Biotechnol Res Int. 2012;2012:976203 - PubMed
  18. Cell Immunol. 2001 May 25;210(1):66-75 - PubMed
  19. Eur J Med Res. 2005 Aug 17;10(8):325-31 - PubMed
  20. J Surg Res. 2012 Aug;176(2):503-9 - PubMed
  21. J Med Food. 2012 Apr;15(4):344-9 - PubMed
  22. Clin Immunol. 2008 Mar;126(3):345-52 - PubMed
  23. Am J Chin Med. 2005;33(1):95-105 - PubMed
  24. Immunol Invest. 2008;37(4):263-77 - PubMed
  25. J Nutr. 2006 May;136(5):1141-4 - PubMed
  26. Neurogastroenterol Motil. 2011 Aug;23(8):745-e331 - PubMed
  27. J Sci Food Agric. 2014 Mar 30;94(5):943-50 - PubMed
  28. Burns. 2012 Nov;38(7):1035-40 - PubMed
  29. Int Immunopharmacol. 2006 Dec 20;6(13-14):2038-46 - PubMed
  30. Clin Immunol. 2002 Aug;104(2):183-90 - PubMed

Publication Types